Amrubicin

Indication

Extensive stage

• Amrubicin 40 mg/m2/d in 20 ml of normal saline iv over 5 min d1-3 q3w

References

Onoda S et al. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301. J Clin Oncol 2006; 24:5448